Skip to content

ANI PHARMACEUTICALS, INC: filings

Every ANI PHARMACEUTICALS, INC annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 2026471280001023024-26-000069
10-Q2026-05-08fiscal Q1 202647980001023024-26-000050
10-K2026-02-27fiscal FY 2025551420001023024-26-000014
10-Q2025-11-07fiscal Q3 2025481280001023024-25-000108
10-Q2025-08-08fiscal Q2 2025461240001023024-25-000082
10-Q2025-05-09fiscal Q1 202546940001023024-25-000046
10-K2025-02-28fiscal FY 2024511350001023024-25-000015
10-Q2024-11-08fiscal Q3 2024481280001023024-24-000102
10-Q2024-08-06fiscal Q2 2024471270001023024-24-000085
10-Q2024-05-10fiscal Q1 202446950001023024-24-000057
10-K2024-02-29fiscal FY 2023531390001023024-24-000026
10-Q2023-11-08fiscal Q3 2023471270001023024-23-000043
10-Q2023-08-09fiscal Q2 2023471270001023024-23-000017
10-Q2023-05-08fiscal Q1 202348990001023024-23-000010
10-K2023-03-09fiscal FY 2022541380001023024-23-000005
10-Q2022-11-09fiscal Q3 2022491300001023024-22-000021
10-Q2022-08-08fiscal Q2 2022481310001023024-22-000017
10-Q2022-05-10fiscal Q1 2022501040001023024-22-000008
10-K2022-03-15fiscal FY 2021541420001023024-22-000004
10-Q2021-11-01fiscal Q3 2021491360001023024-21-000021
10-Q2021-08-06fiscal Q2 2021491360001023024-21-000017
10-Q2021-05-07fiscal Q1 2021501040001023024-21-000012
10-K2021-03-11fiscal FY 2020531870001023024-21-000007
10-Q2020-11-05fiscal Q3 2020511440001023024-20-000008
10-Q2020-08-06fiscal Q2 2020511420001558370-20-009520
10-Q2020-05-07fiscal Q1 2020521080001104659-20-057791
10-K2020-02-27fiscal FY 2019541830001104659-20-025744
10-Q2019-11-06fiscal Q3 2019531490001104659-19-060283
10-Q2019-08-07fiscal Q2 2019521470001144204-19-038053
10-Q2019-05-09fiscal Q1 2019531090001144204-19-024656
10-K2019-02-27fiscal FY 2018531830001144204-19-010541
10-Q2018-11-06fiscal Q3 2018501410001144204-18-057627
10-Q2018-08-07fiscal Q2 2018501400001144204-18-042444
10-Q2018-05-08fiscal Q1 201848980001144204-18-026158
10-K2018-02-27fiscal FY 2017501740001144204-18-011197
10-Q2017-11-02fiscal Q3 2017481330001144204-17-055663
10-Q2017-08-03fiscal Q2 2017481330001144204-17-040342
10-Q2017-05-04fiscal Q1 201746930001144204-17-024566
10-K2017-03-02fiscal FY 2016491630001144204-17-012507
10-Q2016-11-03fiscal Q3 2016431210001144204-16-131405
10-Q2016-08-04fiscal Q2 2016431210001144204-16-116629
10-Q2016-05-05fiscal Q1 201643870001144204-16-099268
10-K2016-02-23fiscal FY 2015481590001144204-16-083848
10-Q2015-11-03fiscal Q3 2015451240001144204-15-062504
10-Q2015-08-04fiscal Q2 2015461260001144204-15-046165
10-Q2015-05-05fiscal Q1 201545900001144204-15-027635
10-K2015-02-23fiscal FY 201447950001144204-15-011270
10-Q2014-11-10fiscal Q3 2014441230001144204-14-066225
10-Q2014-08-07fiscal Q2 2014431230001144204-14-047549
10-Q2014-05-12fiscal Q1 201442850001144204-14-029299
10-K2014-02-28fiscal FY 201340820001144204-14-012277
10-Q2013-11-07fiscal Q3 2013391080001144204-13-059427
10-Q2013-08-09fiscal Q2 2013381060001144204-13-044160
10-Q2013-05-10fiscal Q1 201317340001104659-13-040291
10-K2013-02-28fiscal FY 2012291120001104659-13-016148
10-Q2012-11-08fiscal Q3 201223660001104659-12-076010
10-Q2012-08-01fiscal Q2 201221590001104659-12-053288
10-Q2012-05-08fiscal Q1 201221430001104659-12-034524
10-K2012-03-13fiscal FY 201123630001104659-12-017928
10-Q2011-11-09fiscal Q3 201123620001104659-11-062750
10-Q2011-08-05fiscal Q2 201125690001104659-11-044302

Inspect the source

Entity
ANI PHARMACEUTICALS, INC / CIK 0001023024
Captured
2026-09-20T05:13:47.462Z
SEC response SHA-256
73f151e92444492f6e76683dd14e436bd7ae49ff3f0c015ea516484800094ee5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001023024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))